A detailed history of Verition Fund Management LLC transactions in Dexcom Inc stock. As of the latest transaction made, Verition Fund Management LLC holds 30,438 shares of DXCM stock, worth $2.44 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
30,438
Previous 41,597 26.83%
Holding current value
$2.44 Million
Previous $4.72 Million 56.76%
% of portfolio
0.01%
Previous 0.03%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$64.0 - $116.06 $714,176 - $1.3 Million
-11,159 Reduced 26.83%
30,438 $2.04 Million
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $1.43 Million - $1.83 Million
13,001 Added 45.46%
41,597 $4.72 Million
Q1 2024

May 14, 2024

BUY
$114.22 - $140.1 $1.39 Million - $1.7 Million
12,150 Added 73.88%
28,596 $3.97 Million
Q4 2023

Feb 14, 2024

SELL
$75.49 - $124.16 $3.17 Million - $5.21 Million
-41,991 Reduced 71.86%
16,446 $2.04 Million
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $5.03 Million - $8.06 Million
58,437 New
58,437 $5.45 Million
Q1 2023

May 15, 2023

SELL
$104.0 - $122.92 $701,168 - $828,726
-6,742 Reduced 14.06%
41,209 $4.79 Million
Q4 2022

Feb 14, 2023

SELL
$84.98 - $122.67 $195,454 - $282,141
-2,300 Reduced 4.58%
47,951 $5.43 Million
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $2.87 Million - $3.54 Million
37,574 Added 296.4%
50,251 $4.05 Million
Q2 2022

Aug 15, 2022

SELL
$67.99 - $132.89 $247,007 - $482,789
-3,633 Reduced 22.27%
12,677 $945,000
Q1 2022

May 13, 2022

BUY
$94.08 - $130.2 $429,098 - $593,842
4,561 Added 38.82%
16,310 $8.34 Million
Q4 2021

May 03, 2022

SELL
$129.87 - $162.82 $1.39 Million - $1.74 Million
-10,700 Reduced 47.66%
11,749 $6.31 Million
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $2.75 Million - $3.45 Million
21,192 Added 1685.92%
22,449 $12.1 Million
Q3 2021

Nov 15, 2021

BUY
$106.71 - $143.18 $134,134 - $179,977
1,257 New
1,257 $687,000
Q2 2021

Aug 16, 2021

SELL
$80.99 - $107.93 $434,997 - $579,692
-5,371 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$84.79 - $104.74 $22,638 - $27,965
267 Added 5.23%
5,371 $482,000
Q4 2020

Feb 16, 2021

BUY
$78.0 - $104.5 $398,112 - $533,368
5,104 New
5,104 $1.89 Million
Q3 2020

Nov 16, 2020

SELL
$95.51 - $112.95 $189,014 - $223,528
-1,979 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$62.68 - $105.34 $124,043 - $208,467
1,979 New
1,979 $802,000
Q1 2020

May 15, 2020

SELL
$47.79 - $75.63 $283,346 - $448,410
-5,929 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$36.62 - $57.29 $217,119 - $339,672
5,929 New
5,929 $1.3 Million
Q3 2019

Nov 14, 2019

SELL
$35.53 - $43.8 $51,589 - $63,597
-1,452 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$27.84 - $38.92 $98,581 - $137,815
-3,541 Reduced 70.92%
1,452 $218,000
Q1 2019

May 15, 2019

BUY
$28.07 - $38.18 $140,153 - $190,632
4,993 New
4,993 $595,000
Q4 2018

Feb 14, 2019

SELL
$26.99 - $37.37 $793,425 - $1.1 Million
-29,397 Closed
0 $0
Q3 2018

Nov 15, 2018

BUY
$23.35 - $36.72 $534,668 - $840,814
22,898 Added 352.33%
29,397 $4.21 Million
Q2 2018

Aug 15, 2018

BUY
$17.54 - $25.22 $113,992 - $163,904
6,499 New
6,499 $617,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.